Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide Extension in Chronic SCI
NCT02025179Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jan 2013
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of teriparatide in osteoporosis, sponsored by Northwestern University. Primary endpoint: Bone Mineral Density of the Total Hip at 24 months. Started Jan 2013; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02025179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025179.